---
title: HPAPI Manufacturing (High-Potency) CDMOs
path: /services/hpapi-manufacturing
companies_count: 37
---

# HPAPI Manufacturing (High-Potency) CDMOs

37 published CDMOs match HPAPI Manufacturing (High-Potency).

Locations in this set include United States, United Kingdom, France, India, Italy, and Germany.

Capabilities that show up most often in this set: Small Molecule, Peptide, Antibody-Drug Conjugate (ADC), Biologics (Other), and Oligonucleotide.

## Matching companies

- [AbbVie Contract Manufacturing](/companies/abbviecontractmfg)
  - Global CMO offering small and large molecule drug substance to drug product manufacturing, with specialized capabilities in antibody drug conjugates, aseptic fill-finish, biologics (mAbs), HPAPI, and eye care across 12 facilities in the US and Europe.
- [Adragos Pharma](/companies/adragos-pharma)
  - Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.
- [Almac Group](/companies/almacgroup)
  - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.
- [Applied Pharmaceutical Innovation](/companies/appliedpharma)
  - Edmonton-based not-for-profit offering integrated CDMO services in sterile fill-finish, oral solid dosage, topical application, and highly potent controlled substance manufacturing. Also provides CRO research, regulatory and quality, and clinical and quantitative support.
- [Ardena](/companies/ardena)
  - Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.
- [Asymchem Laboratories](/companies/asymchem)
  - Asymchem is a CDMO providing integrated API synthesis, drug product development, and biologics manufacturing with specialized capabilities in peptides, oligonucleotides, highly potent compounds, and flow chemistry.
- [Axplora](/companies/axplora)
  - Global CDMO and API manufacturer specializing in complex small molecule development, ADC manufacturing, HPAPIs, and hazardous chemistry across ten production sites in Europe, India, and the US.
- [BSP Pharmaceuticals](/companies/bsppharmaceuticals)
  - BSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply.
- [BioVectra](/companies/biovectra)
  - North American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.
- [Bushu Pharmaceuticals](/companies/bushu-pharma)
  - Bushu Pharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in pharmaceutical contract manufacturing with over 25 years of experience.
- [CMC Pharmaceuticals, Inc.](/companies/cmcpharm)
  - CMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.
- [Cambrex](/companies/cambrex)
  - CDMO offering drug substance and drug product development, manufacturing, and analytical services across small molecules, peptides, and specialty chemistries.
- [Carbogen Amcis](/companies/carbogen-amcis)
  - Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.
- [CordenPharma](/companies/cordenpharma)
  - Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees.
- [Curia](/companies/curiaglobal)
  - Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.
- [Dalton Pharma Services](/companies/dalton)
  - Health Canada–approved and FDA-inspected cGMP contract manufacturer offering integrated drug discovery, development, and manufacturing services including custom synthesis, API production, formulation development, and sterile fill-finish for vials, syringes, and cartridges.
- [Divi's Laboratories](/companies/divislabs)
  - World's largest API manufacturer and trusted CDMO partner for 25+ years, offering generic APIs, custom synthesis, peptides, and nutraceutical ingredients to 100+ countries with complete backward integration and green chemistry principles.
- [Flamma](/companies/flammagroup)
  - Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale.
- [HAS Healthcare Advanced Synthesis SA](/companies/hashealthcare)
  - HAS Healthcare Advanced Synthesis is a Swiss CDMO producing cGMP APIs, HPAPIs and anticancer compounds from clinical to commercial use. Recent Swissmedic milestones include approval of its expanded Reduced Folates unit and inspection of its new ADC suite.
- [Hikal](/companies/hikal)
  - Hikal is a contract development and manufacturing partner for pharmaceuticals, biotech, and specialty chemicals, offering API synthesis, process development, and custom manufacturing at FDA-approved facilities across five Indian manufacturing sites.
